MSFT   184.29 (-0.34%)
FB   230.86 (-0.80%)
AMZN   2,470.18 (-0.09%)
CGC   16.80 (+4.09%)
BABA   217.86 (+1.65%)
MU   48.23 (+3.01%)
GE   7.29 (+3.40%)
AMD   52.55 (-1.85%)
T   31.42 (+1.39%)
ACB   14.59 (+0.41%)
F   6.08 (+3.05%)
DIS   121.38 (+2.21%)
NFLX   421.25 (-1.42%)
BAC   26.03 (+4.79%)
BA   165.15 (+7.72%)
MSFT   184.29 (-0.34%)
FB   230.86 (-0.80%)
AMZN   2,470.18 (-0.09%)
CGC   16.80 (+4.09%)
BABA   217.86 (+1.65%)
MU   48.23 (+3.01%)
GE   7.29 (+3.40%)
AMD   52.55 (-1.85%)
T   31.42 (+1.39%)
ACB   14.59 (+0.41%)
F   6.08 (+3.05%)
DIS   121.38 (+2.21%)
NFLX   421.25 (-1.42%)
BAC   26.03 (+4.79%)
BA   165.15 (+7.72%)
MSFT   184.29 (-0.34%)
FB   230.86 (-0.80%)
AMZN   2,470.18 (-0.09%)
CGC   16.80 (+4.09%)
BABA   217.86 (+1.65%)
MU   48.23 (+3.01%)
GE   7.29 (+3.40%)
AMD   52.55 (-1.85%)
T   31.42 (+1.39%)
ACB   14.59 (+0.41%)
F   6.08 (+3.05%)
DIS   121.38 (+2.21%)
NFLX   421.25 (-1.42%)
BAC   26.03 (+4.79%)
BA   165.15 (+7.72%)
MSFT   184.29 (-0.34%)
FB   230.86 (-0.80%)
AMZN   2,470.18 (-0.09%)
CGC   16.80 (+4.09%)
BABA   217.86 (+1.65%)
MU   48.23 (+3.01%)
GE   7.29 (+3.40%)
AMD   52.55 (-1.85%)
T   31.42 (+1.39%)
ACB   14.59 (+0.41%)
F   6.08 (+3.05%)
DIS   121.38 (+2.21%)
NFLX   421.25 (-1.42%)
BAC   26.03 (+4.79%)
BA   165.15 (+7.72%)
Log in

NASDAQ:SLPSimulations Plus Stock Price, Forecast & News

$51.56
-0.55 (-1.06 %)
(As of 06/3/2020 11:20 AM ET)
Add
Compare
Today's Range
$51.32
Now: $51.56
$52.26
50-Day Range
$35.86
MA: $40.43
$50.67
52-Week Range
$24.08
Now: $51.56
$53.76
Volume22,690 shs
Average Volume333,388 shs
Market Capitalization$916.22 million
P/E Ratio103.12
Dividend Yield0.46%
Beta-0.15
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers MedChem Studio, a software tool for data mining and designing new molecules; KIWI, a cloud-based Web application to organizes, processes, maintains, and communicates the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; and RENAsym for investigating and predicting drug-induced or acute kidney injury. Further, the company provides population modeling and simulation contract research services for the pharmaceutical and biotechnology industries; and clinical-pharmacology-based consulting services in support of regulatory submissions. It sells its pharmaceutical/chemistry software to pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies. The company was founded in 1996 and is headquartered in Lancaster, California.
Read More
Simulations Plus logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.4Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.02 out of 5 stars


Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:SLP
CUSIPN/A
Phone661-723-7723

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$33.97 million
Cash Flow$0.64 per share
Book Value$2.15 per share

Profitability

Net Income$8.58 million

Miscellaneous

Employees93
Market Cap$916.22 million
Next Earnings Date7/8/2020 (Estimated)
OptionableOptionable

Receive SLP News and Ratings via Email

Sign-up to receive the latest news and ratings for SLP and its competitors with MarketBeat's FREE daily newsletter.

Simulations Plus (NASDAQ:SLP) Frequently Asked Questions

How has Simulations Plus' stock been impacted by COVID-19 (Coronavirus)?

Simulations Plus' stock was trading at $30.20 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SLP shares have increased by 70.7% and is now trading at $51.56. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Simulations Plus?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Simulations Plus in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Simulations Plus.

When is Simulations Plus' next earnings date?

Simulations Plus is scheduled to release its next quarterly earnings announcement on Wednesday, July 8th 2020. View our earnings forecast for Simulations Plus.

How were Simulations Plus' earnings last quarter?

Simulations Plus, Inc. (NASDAQ:SLP) released its quarterly earnings data on Thursday, April, 9th. The technology company reported $0.12 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.14 by $0.02. The technology company had revenue of $10.35 million for the quarter, compared to the consensus estimate of $9.68 million. Simulations Plus had a net margin of 24.28% and a return on equity of 23.83%. View Simulations Plus' earnings history.

How often does Simulations Plus pay dividends? What is the dividend yield for Simulations Plus?

Simulations Plus declared a quarterly dividend on Thursday, April 9th. Investors of record on Friday, April 24th will be given a dividend of $0.06 per share on Friday, May 1st. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date is Thursday, April 23rd. View Simulations Plus' dividend history.

What price target have analysts set for SLP?

1 brokerages have issued 1-year target prices for Simulations Plus' shares. Their forecasts range from $40.00 to $40.00. On average, they anticipate Simulations Plus' share price to reach $40.00 in the next year. This suggests that the stock has a possible downside of 22.4%. View analysts' price targets for Simulations Plus.

Has Simulations Plus been receiving favorable news coverage?

Press coverage about SLP stock has trended somewhat positive on Wednesday, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Simulations Plus earned a coverage optimism score of 0.6 on InfoTrie's scale. They also gave media stories about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutSimulations Plus.

Who are some of Simulations Plus' key competitors?

What other stocks do shareholders of Simulations Plus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Simulations Plus investors own include Advanced Micro Devices (AMD), Verizon Communications (VZ), AGNC Investment (AGNC), Altria Group (MO), NVIDIA (NVDA), Omega Healthcare Investors (OHI), AT&T (T), Cisco Systems (CSCO), ServiceNow (NOW) and Paypal (PYPL).

Who are Simulations Plus' key executives?

Simulations Plus' management team includes the following people:
  • Mr. Walter S. Woltosz, Co-Founder & Chairman (Age 74)
  • Mr. Shawn M. O'Connor, Chief Exec. Officer (Age 59)
  • Mr. John R. Kneisel, Chief Financial Officer (Age 61)
  • Dr. Thaddeus Henry Grasela Jr., Pharm.D., PharmD, Ph.D., Pres Buffalo Division, Director of Simulations Plus & Director (Age 65)
  • Mr. John Anthony DiBella, Pres of the Lancaster Division (Age 39)

What is Simulations Plus' stock symbol?

Simulations Plus trades on the NASDAQ under the ticker symbol "SLP."

Who are Simulations Plus' major shareholders?

Simulations Plus' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.82%), William Blair Investment Management LLC (3.11%), Wasatch Advisors Inc. (1.83%), Russell Investments Group Ltd. (1.55%), Congress Asset Management Co. MA (1.20%) and Ranger Investment Management L.P. (1.07%). Company insiders that own Simulations Plus stock include David L Ralph, John Kenneth Paglia and Walter S Woltosz. View institutional ownership trends for Simulations Plus.

Which major investors are selling Simulations Plus stock?

SLP stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, Wedge Capital Management L L P NC, UBS Group AG, Morgan Stanley, Canton Hathaway LLC, Bank of New York Mellon Corp, Strs Ohio, and Parametric Portfolio Associates LLC. Company insiders that have sold Simulations Plus company stock in the last year include John Kenneth Paglia, and Walter S Woltosz. View insider buying and selling activity for Simulations Plus.

Which major investors are buying Simulations Plus stock?

SLP stock was bought by a variety of institutional investors in the last quarter, including Congress Asset Management Co. MA, Invesco Ltd., Wasatch Advisors Inc., William Blair Investment Management LLC, Aviva PLC, Mutual of America Capital Management LLC, Russell Investments Group Ltd., and Wells Fargo & Company MN. View insider buying and selling activity for Simulations Plus.

How do I buy shares of Simulations Plus?

Shares of SLP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Simulations Plus' stock price today?

One share of SLP stock can currently be purchased for approximately $51.56.

How big of a company is Simulations Plus?

Simulations Plus has a market capitalization of $916.22 million and generates $33.97 million in revenue each year. The technology company earns $8.58 million in net income (profit) each year or $0.48 on an earnings per share basis. Simulations Plus employs 93 workers across the globe.

What is Simulations Plus' official website?

The official website for Simulations Plus is www.simulations-plus.com.

How can I contact Simulations Plus?

Simulations Plus' mailing address is 42505 10TH STREET WEST, LANCASTER CA, 93534. The technology company can be reached via phone at 661-723-7723 or via email at [email protected]

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.